Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma

Clinical trial NCT01004874 · COMPLETED

Trial details

NCT number: NCT01004874
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Glioma Glioblastoma Gliosarcoma

Start date: 2009-12-30
Primary completion: 2012-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.